# Free amino acid–rich egg yolk protein hydrolysate promotes osteogenesis of MC3T3-E1 cells association with β-catenin nuclear translocation

**Authors:** Yulong Zheng, ChoYeon Park, HyeJi Hwang, Byung-Hak Kim, Sang Jae Park, Il-Jun Kang

PMC · DOI: 10.3389/fnut.2026.1774605 · Frontiers in Nutrition · 2026-02-19

## TL;DR

A protein hydrolysate from egg yolk promotes bone cell development and could help treat bone diseases.

## Contribution

The study identifies a new functional food ingredient with potential for preventing or improving bone metabolic diseases.

## Key findings

- Y-PEP enhanced osteoblast differentiation and mineralization in a dose-dependent manner.
- Y-PEP increased β-catenin levels and promoted its nuclear translocation, upregulating osteogenesis-related genes.
- The amino acid composition of Y-PEP synergistically supports osteogenesis through metabolism and signaling.

## Abstract

Promoting osteogenesis is a key approach to preventing and improving bone metabolic diseases.

This study investigated the impact of free amino acid-rich egg yolk protein hydrolysate (Y-PEP) on MC3T3-E1 osteoblast differentiation and mineralization.

Free amino acids in Y-PEP were quantified using a high-speed amino acid analyzer. MC3T3-E1 cells were osteogenically induced with Y-PEP (5–100 μg/mL), and cell viability (72 h), alkaline phosphatase activity and collagen synthesis (day 9), as well as calcium deposition and osteocalcin production (day 18) were assessed. Moreover, runt-related transcription factor 2/osterix mRNA (qRT-PCR) and total/cytosolic/nuclear β-catenin and β-catenin phosphorylation (western blot) were measured.

Twenty-one amino acids, including leucine, lysine, arginine, glutamic acid, and valine, were identified and quantified in Y-PEP by comparing retention times and peak areas with amino acid mixture standard solutions. Y-PEP concentrations below 100 μg/mL had no impact on MC3T3-E1 osteoblast viability. Y-PEP enhanced osteoblast differentiation markers in a dose-dependent manner at concentrations from 5 to 100 μg/mL and promoted mineralization markers in mature osteoblasts dose-dependently at 25–50 μg/mL. The pro-osteogenic effect of Y-PEP may involve increasing total cellular β-catenin levels and promoting β-catenin nuclear translocation rate to upregulate transcription of osteogenesis-associated genes. The osteogenic activity of Y-PEP may result from the synergistic effects among signal transduction, metabolism, and mineral handling driven by its complex amino acid composition.

Y-PEP can promote osteogenesis in MC3T3-E1 cells and has the potential to serve as a functional food ingredient for preventing or improving metabolic bone diseases.

## Linked entities

- **Genes:** SP7 (Sp7 transcription factor) [NCBI Gene 121340], ctnnb1.S (catenin beta 1 S homeolog) [NCBI Gene 380441]
- **Proteins:** ctnnb1.S (catenin beta 1 S homeolog)
- **Chemicals:** leucine (PubChem CID 857), lysine (PubChem CID 866), arginine (PubChem CID 232), glutamic acid (PubChem CID 611), valine (PubChem CID 1182)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Runx2 (runt related transcription factor 2) [NCBI Gene 12393] {aka AML3, CBF-alpha-1, Cbf, Cbfa-1, Cbfa1, LS3}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, Alpl (alkaline phosphatase, liver/bone/kidney) [NCBI Gene 11647] {aka ALP, APTNAP, Akp-2, Akp2, TNAP, TNSALP}, Ctnnb1 (catenin beta 1) [NCBI Gene 12387] {aka Bfc, Catnb, Mesc}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, Bglap2 (bone gamma-carboxyglutamate protein 2) [NCBI Gene 12097] {aka BGP2, Bglap1, Bgp, Og2, mOC-B}, Acp5 (acid phosphatase 5, tartrate resistant) [NCBI Gene 11433] {aka TRACP, TRAP}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Sp7 (Sp7 transcription factor 7) [NCBI Gene 170574] {aka 6430578P22Rik, C22, Osx}, RUNX2 (RUNX family transcription factor 2) [NCBI Gene 860] {aka AML3, CBF-alpha-1, CBFA1, CCD, CCD1, CLCD}, alp (alopecia, recessive) [NCBI Gene 11691], ALPP (alkaline phosphatase, placental) [NCBI Gene 250] {aka ALP, PALP, PLAP, PLAP-1}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, SP7 (Sp7 transcription factor) [NCBI Gene 121340] {aka OI11, OI12, OSX, osterix}
- **Diseases:** cytotoxicity (MESH:D064420), bone diseases (MESH:D001847), osteoporosis (MESH:D010024), associated (MESH:D018886), inflammation (MESH:D007249), metabolic diseases (MESH:D008659), Fragility fractures (MESH:D005600), metabolic bone diseases (MESH:D001851)
- **Chemicals:** beta-glycerophosphate (MESH:C031463), Amino acid (MESH:D000596), urea (MESH:D014508), arginine (MESH:D001120), PF-1-PF-4 (-), H2S. (MESH:D006862), ornithine (MESH:D009952), HEPES (MESH:D006531), penicillin (MESH:D010406), lysine (MESH:D008239), PVDF (MESH:C024865), lecithin (MESH:D054709), Calcium (MESH:D002118), ninhydrin (MESH:D009555), glutamine (MESH:D005973), CO2 (MESH:D002245), cysteine (MESH:D003545), 17-beta-estradiol (MESH:D004958), Triton X-100 (MESH:D017830), streptomycin (MESH:D013307), cystathionine (MESH:D003540), metal (MESH:D008670), ammonia (MESH:D000641), alpha-MEM (MESH:C420642), branched-chain amino acids (MESH:D000597), glutamic acid (MESH:D018698), SDS (MESH:D012967), ascorbic acid (MESH:D001205), leucine (MESH:D007930), valine (MESH:D014633), iron (MESH:D007501)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** MC3T3-E1 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0409)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12960115/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12960115/full.md

## References

49 references — full list in the complete paper: https://tomesphere.com/paper/PMC12960115/full.md

---
Source: https://tomesphere.com/paper/PMC12960115